Dr. Benjamin has served as a member of our board since September 2020. Dr. Benjamin is currently the founder and chief executive officer of, and is a practicing physician at, BayouClinic, Inc., a hospital and healthcare company, since January 1990. Dr. Benjamin was appointed as the 18th United States Surgeon General by President Barack Obama in July 2009 and served in that role from November 2009 to August 2013. In addition, Dr. Benjamin has approximately 30 years of experience as a practicing family physician. Dr. Benjamin has served as the founder and chief executive officer of the Gulf States Health Policy Center since June 2013, and as the NOLA.com/Times Picayune Endowed Chair in Public Health Sciences at Xavier University of Louisiana since September 2013. Dr. Benjamin currently serves as a member of the boards of directors of each of Computer Programs and Systems, Inc., a public technology company, since November 2017, ConvaTec Group plc, a public medical products and technologies company, since August 2017, Diplomat Pharmacy, Inc., a private company providing specialty pharmacy services, following its acquisition by OptimRx, since April 2017, and Kaiser Foundation Hospitals and Health Plan since June 2015. Dr. Benjamin also serves on the advisory board of HealthQuest Capital, a private growth capital firm, since May 2020. Dr. Benjamin served on the board of directors of Alere Inc., a private medical device company, from December 2013 to July 2015, Oak Street Health, Inc., a public healthcare services company, from October 2020 - May 2023, Ascension Health Alliance, a private healthcare company from June 2014 - June 2023, and as a member of the March of Dimes Board of Trustees from June 2014 to June 2019. Dr. Benjamin holds a B.S. in Chemistry from Xavier University of Louisiana, an M.D. from the University of Alabama at Birmingham, and an M.B.A. from Tulane University.
What is Regina M. Benjamin's net worth?
The estimated net worth of Regina M. Benjamin is at least $1.02 million as of October 10th, 2025. Dr. Benjamin owns 19,839 shares of Doximity stock worth more than $1,017,324 as of December 4th. This net worth evaluation does not reflect any other investments that Dr. Benjamin may own. Learn More about Regina M. Benjamin's net worth.
How do I contact Regina M. Benjamin?
Has Regina M. Benjamin been buying or selling shares of Doximity?
During the last quarter, Regina M. Benjamin has sold $354,200.00 in shares of Doximity stock. Most recently, Regina M. Benjamin sold 5,000 shares of the business's stock in a transaction on Friday, October 10th. The shares were sold at an average price of $70.84, for a transaction totalling $354,200.00. Following the completion of the sale, the director now directly owns 19,839 shares of the company's stock, valued at $1,405,394.76. Learn More on Regina M. Benjamin's trading history.
Who are Doximity's active insiders?
Are insiders buying or selling shares of Doximity?
In the last twelve months, insiders at the sold shares 14 times. They sold a total of 135,000 shares worth more than $8,322,130.00. The most recent insider tranaction occured on November, 3rd when Director Kira Scherer Wampler sold 2,000 shares worth more than $132,880.00. Insiders at Doximity own 31.3% of the company.
Learn More about insider trades at Doximity. Information on this page was last updated on 11/3/2025.
